Download Citation
Article Source:
Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza
Scott C,
Kankanala J,
Foster TL,
Goldhill DH,
Bao P,
et al.
(2020)
Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza.
PLOS Pathogens 16(8): e1008716.
https://doi.org/10.1371/journal.ppat.1008716